Search Results 211-220 of 16564 for ������������KA���:ZA31���24������ ���������������������������������

  1. Decision Aids for Patients with Nonvalvular Chronic Atrial Fibrillation - Mayo Clinic

    Madeleine M; Cameron KA. Kenzie A; Cavanaugh KL. Kerri L; Steinberg BA. Benjamin A; Passman R. Rod; Kansal P. Preeti; Guzman A. Adriana; Chen E. Emily ...

  2. Saliva and remote monitoring of active Cytomegalovirus infection and symptoms during ovarian cancer treatment - Mayo Clinic

    Rochester, Minnesota: 24-011332. NCT ID: NCT06870539. Sponsor Protocol Number: 24-011332. About this study. The purpose of this project is to determine the ...

  3. MAYO CLINIC RADIO

    Lift off with us Saturday, May 24, when we have out of this world researchers on Mayo Clinic Radio! Abba Zubair M.D., Ph.D., from Mayo Clinic in Florida, ...

  4. Joel Streed | Mayo Clinic News Network - Page 25 of 170

    They had three children already and thought this ultrasound would be as routine as the ones that had[...] By Joel Streed • April 24, 2022 ... 24 · 25 · 26 · 27 ...

  5. Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

    Jacksonville, Florida: 24-011255; Scottsdale/Phoenix, Arizona: 24-011255. NCT ID: NCT06556654. Sponsor Protocol Number: TBR 22-07. About this study. This record ...

  6. Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer - Mayo Clinic

    ... 24 months prior to the most recent CIS diagnosis Cohort B: -Participants with persistent or recurrent CIS (± Ta/T1) who are BCG unresponsive within 12 ...

  7. Uterine fibroids - Doctors and departments - Mayo Clinic

    Learn about these common noncancerous growths and what to do if you have symptoms such as heavy menstrual bleeding.

  8. Publications - Leslie T. Cooper, Jr., M.D. - Mayo Clinic

    2025 Apr 24 [Epub ahead of print] View ... 2022 Nov; 24 (11):2000-2018 Epub 2022 Oct 06. View ... Matsumori A, Auda ME, Bruno KA, Shapiro KA, Kato ...

  9. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    Rochester, Minnesota: 24-012593. NCT ID: NCT06548542. Sponsor Protocol Number: AbbVie M24-885. About this study. Crohn's disease (CD) is a long-lasting disease ...

  10. Clinical Trials - CONVERGE Post-Approval Study (PAS)

    Rochester, Minnesota: 24-009046. NCT ID: NCT05393180. Sponsor Protocol Number: CP2021-1. About this study. The primary objective of CONVERGE PAS is to evaluate ...